


Pimera Therapeutics Revenue
Biotechnology Research • United States • 1-10 Employees
Pimera Therapeutics revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at Pimera Therapeutics
Mustapha Haddach
Founder & CEO
Company overview
| Headquarters | United States |
| Websites | |
| Keywords | Cancer And Biotech |
| Employees | 1-10 |
| Socials |
About Pimera Therapeutics
Pimera Therapeutics, Inc. is a privately held, clinical-stage biotechnology company focused on developing breakthrough therapeutics for cancer and other major unmet medical needs. Pimera’s lead program, PMR-116, is designed to target dysregulated RNA polymerase I (Pol I) transcription in MYC-driven cancers. Pol I transcription of ribosomal RNA genes is tightly regulated downstream of oncogenic pathways, and its dysregulation is a common feature in cancer and other human diseases. Pimera is advancing PMR-116 through dose escalation in a Phase 1a/1b clinical trial.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Pimera Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Pimera Therapeutics Tech Stack
Discover the technologies and tools that power Pimera Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Form builders
Video players
JavaScript libraries
JavaScript libraries
Font scripts
WordPress themes
JavaScript libraries
Programming languages
WordPress plugins
Blogs
UI frameworks
SEO
Frequently asked questions
4.8
40,000 users



